Jens Tornoe

Title: Jens Tornoe: Innovator in Neublastin Research

Introduction

Jens Tornoe is a prominent inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing Neublastin polypeptides. His innovative work aims to enhance the delivery of therapeutic agents to specific regions of the nervous system.

Latest Patents

Jens Tornoe holds a patent for the "Secretion of Neublastin." This invention focuses on improved methods and compositions for producing Neublastin polypeptides. It also addresses the local delivery of Neublastin to targeted areas of the nervous system, including the central nervous system and the eye, potentially through gene therapy. The patent includes Neublastin expression constructs that do not encode a pro-region of the polypeptide, resulting in increased secretion of bioactive Neublastin. Furthermore, the invention encompasses the delivery of Neublastin from transduced or transfected cells encapsulated in a macrocapsule with a semipermeable membrane. Additionally, it concerns mammalian cells capable of producing Neublastin in greater quantities.

Career Highlights

Jens Tornoe is associated with Nsgene A/S, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, particularly in the context of neurobiology and therapeutic applications.

Collaborations

Throughout his career, Jens has collaborated with notable colleagues, including Lars U Wahlberg and Mette Gronborg. These partnerships have contributed to the success and impact of his research initiatives.

Conclusion

Jens Tornoe's innovative work in the field of Neublastin research exemplifies the potential of biotechnology to address complex medical challenges. His contributions continue to pave the way for advancements in therapeutic delivery systems.